Table 1.
Control | ASD | |
---|---|---|
Age (years) | 3–12, Median 5 | 3–15, Median 6 |
Sex | 8F, 15M, | 4F, 19M |
Primary Diagnosis2 | Reactive airway disease and/or allergy: 7 | Autistic disorder: 10 |
Comorbidity2 | None | PDD-NOS: 11 Asperger’s disorder: 2 GI dysfunction: 10 Epilepsy: 2 Immune dysfunction: 3 ADHD: 6 Anxiety disorder: 4 Mood disorder: 7 |
Medication3 | albuterol (5), nasal steroid (2) | topiramate (1), valproate (1), risperidone (2), aripiprazole (1), nasal steroid (2), montelukast sodium (3), oxcarbamazepine (1) |
The total n-umber of subjects for each group is 23.
The numbers represent the number of subjects with the corresponding diagnosis.
The medication used during PSG studies. The number in the parentheses presents the number of subject taking the medication.